An evaluation of the efficacy and safety of meprobamate in combination analgesics and the likely economic impact of its withdrawal
No Thumbnail Available
Date
2002
Authors
Peter, Amanda, Clare
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
South Africa has the highest number of registered medicine containing meprobamate in combination analgesics and is the only country that markets a combination that includes paracetamol, caffeine and codeine. In November 1998 the \medicine Control Council issued a circular (11/98) to the pharmaceutical industry requesting evidence that meprobamate contributes meaningfully to the therapeutic effect in combination analgesics and asked for comment on the risk-benefit ratio
Description
A research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, in partial fulfilment of the requirements for the degree of Master of Science ( Medicine ) in pharmaceutical affairs
Johannesburg
Keywords
economic factor, profit